« Return to News | Awards & Advancement

Clinilabs selected for investigational medication study

Friday, July 15, 2011 10:43 AM

CRO Clinilabs has been selected to conduct a clinical research study on the effects of an investigational medication on the sleep of healthy volunteers.

This study uses an experimental model to assess the effects of an investigational medication on nighttime sleep and morning alertness in healthy volunteers.  President and CEO Dr. Gary Zammit said the use of experimental models and biomarkers are increasingly important in early-phase drug development. 

“The current study employs an experimental model of disturbed sleep that can be used as an assay to assess the potential therapeutic effects that drugs will have in patients with sleep disorders,” said Dr. Zammit. “The model will allow our client to determine if their drug should advance to later and more costly phases of testing.” 

The use of such models is likely to become more common as drug makers seek more efficient ways to test investigational medications.

Clinilabs is currently enrolling healthy male and female volunteers between the ages of 21 and 65 years who are not sleep deprived and who maintain a regular sleep/wake schedule. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.